There is a reason I am enthusiastic about stem cell procedures. American medicine is the best in the world. Just ask an American doctor. I want to know how much ammunition these docs have in their holsters. How often are physicians able to hit the broad side of the barn with whatever they are firing? Near as I can tell, too often they are shooting blanks. Many cancers, Alzheimer’s disease and a host of other conditions run their course with little to stop them.
I embarked on a six-month regimen of chemotherapy. The drug was Cytoxan, commonly used to treat cancers. A neurologist prescribed this toxic drug for me based on scant evidence that it would accomplish anything with MS. It didn’t. In fairness, I had asked him to think outside the box and try anything that might work. Beware of what you ask for. The doctor was only following patient’s orders.
The Cytoxan weakened me, turned my hair white, what was left of it, and turned me into a fragile fellow who might take a tumble in a strong wind.
Chronic conditions by definition are incurable. Often they can be managed, sometimes survived, often invisible in the rear view mirror. Expectations can be out of whack and highly unrealistic with these conditions. Happy endings are elusive. So we live with uncertainty. Long ago I learned never to stop pushing.
I still hear doctors dismiss stem cell therapy. I have benefited from ears full of negative nonsense regarding the inevitability of failure of stem cell therapy and MS. Neurologists seem to be long on opinions, short on action. There exists an unholy alliance between many neurologists and big pharmaceuticals. Many of these docs take big money from big pharma, consulting and taking the company line. Trust me. They will not be leading the charge away from conventional therapies.
Let me share a secret. We have to get involved. We need to stay on top of developments. We are our best advocates. We have to be prepared to lead the horse to water. Stem cell therapy is real and approaching fast. Think it through, or just stick to the existing drugs, the interferons that may or may not be effective, Tysabri, pulled off the market once and never fixed. The manufacturers all have well oiled PR machines that keep expectations high.
My prediction for 2014 is that the large pharmaceuticals are going to invest heavily in cell therapy. They see the handwriting on the wall and actually can read it. Stay ahead of them. Pursue and learn about these alternative therapies. They may be your futures.